AAAAAA

   
Results: 1-9 |
Results: 9
Costs of type 2 diabetes in Germany - Results of the CODE-2 (R) Study
Authors: Liebl, A Neiss, A Spannheimer, A Reitberger, U Wagner, T Gortz, A
Citation: A. Liebl et al., Costs of type 2 diabetes in Germany - Results of the CODE-2 (R) Study, DEUT MED WO, 126(20), 2001, pp. 585-589
The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients: a randomised controlled clinical trial
Authors: Steuer-Vogt, MK Bonkowsky, V Ambrosch, P Scholz, M Neiss, A Strutz, J Hennig, M Lenarz, T Arnold, W
Citation: Mk. Steuer-vogt et al., The effect of an adjuvant mistletoe treatment programme in resected head and neck cancer patients: a randomised controlled clinical trial, EUR J CANC, 37(1), 2001, pp. 23
Safety of low-density lipoprotein cholesterol reduction with atorvastatin versus simvastatin in a coronary heart disease population (the TARGET TANGIBLE Trial)
Authors: Marz, W Wollschlager, H Klein, G Neiss, A Wehling, M
Citation: W. Marz et al., Safety of low-density lipoprotein cholesterol reduction with atorvastatin versus simvastatin in a coronary heart disease population (the TARGET TANGIBLE Trial), PERFUSION, 12(10), 1999, pp. 427-436
Lipid intervention and coronary artery disease (CAD) in men below 56 yearsof age. The Coronary Intervention Study: CIS
Authors: Rensing, UFE Bestehorn, HP Roskamm, H Petersen, J Betz, P Spinder, M Benesch, L Schemeitat, K Blumchen, G Claus, J Wieland, H Bocker, JF Neiss, A Stiepel, E Mathes, P Kappenberger, L Braunagel, K Peters, K Meister, G Samek, L Schuon, J Leimenstoll, B Kiefer, H
Citation: Ufe. Rensing et al., Lipid intervention and coronary artery disease (CAD) in men below 56 yearsof age. The Coronary Intervention Study: CIS, Z KARDIOL, 88(4), 1999, pp. 270-282
Effects of lovastatin on progression of non-dilated and dilated coronary segments and on restenosis in patients after PTCA - The Cholesterol LoweringAtherosclerosis PTCA Trial (CLAPT)
Authors: Kleemann, A Eckert, S von Eckardstein, A Lepper, W Schernikau, U Gleichmann, U Hanrath, P Fleck, E Neiss, A Kerber, S Assmann, G Breithardt, G
Citation: A. Kleemann et al., Effects of lovastatin on progression of non-dilated and dilated coronary segments and on restenosis in patients after PTCA - The Cholesterol LoweringAtherosclerosis PTCA Trial (CLAPT), EUR HEART J, 20(19), 1999, pp. 1393-1406
Observer bias in acellular pertussis vaccine trials
Authors: von Konig, CHW Schmitt, HJ Neiss, A
Citation: Chw. Von Konig et al., Observer bias in acellular pertussis vaccine trials, PEDIATRICS, 104(3), 1999, pp. 577-578
Safety of low-density lipoprotein cholesterol reduction with atorvastatin versus simvastatin in a coronary heart disease population (the TARGET TANGIBLE trial)
Authors: Marz, W Wollschlager, H Klein, G Neiss, A Wehling, M
Citation: W. Marz et al., Safety of low-density lipoprotein cholesterol reduction with atorvastatin versus simvastatin in a coronary heart disease population (the TARGET TANGIBLE trial), AM J CARD, 84(1), 1999, pp. 7-13
A prognostic score for postherpetic neuralgia in ambulatory patients
Authors: Meister, W Neiss, A Gross, G Doerr, HW Hobel, W Malin, JP von Essen, J Reimann, BY Witke, C Wutzler, P
Citation: W. Meister et al., A prognostic score for postherpetic neuralgia in ambulatory patients, INFECTION, 26(6), 1998, pp. 359-363
Demography, symptomatology, and course of disease in ambulatory zoster patients
Authors: Meister, W Neiss, A Gross, G Doerr, HW Hobel, W Malin, JP von Essen, J Reimann, BY Witke, C Wutzler, P
Citation: W. Meister et al., Demography, symptomatology, and course of disease in ambulatory zoster patients, INTERVIROLO, 41(6), 1998, pp. 272-277
Risultati: 1-9 |